SRRK

NASDAQ · Biotechnology

Scholar Rock Holding Corp

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$48.16

+1.51 (+3.24%)

As of Sep 21, 9:55 PM ET ·

Day Range $46.54 — $49.15

52W Range $27.07 — $61.76

Performance

1D —

1W —

1M —

3M —

6M —

1Y +47.82%

YTD +12.52%

Open$47.35

Previous Close$46.65

Day High$49.15

Day Low$46.54

52W High$61.76

52W Low$27.07

Volume—

Avg Volume2.35M

Market Cap5.97B

P/E Ratio—

EPS$-3.30

SectorBiotechnology

Technical Indicators

Full analysis →

SMA 50 $45.16 Above

SMA 200 $36.91 Above

RSI (14) 59.5 Neutral

Trend Golden Cross Bullish

Analyst Ratings

Strong Buy

24 analysts

23 Buy 1 Hold 0 Sell

Price Target +48.0% upside

Current
$48.16

Target
$71.29

$54.07 $71.29 avg $91.55

Key Financials

	FY 2025	FY 2024	FY 2023
Revenue	910.50M	880.80M	846.68M
Net Income	-11,497,538	-12,296,426	-11,692,649
Profit Margin	-1.3%	-1.4%	-1.4%
EBITDA	-11,509,292	-12,212,052	-11,111,961
Free Cash Flow	-10,999,659	-14,100,591	-9,156,076
Rev Growth	+11.0%	+3.4%	+15.4%
Debt/Equity	0.75	0.83	0.78

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$264.48	+0.20%	74.0	466.74B
AMGN	Amgen Inc	$393.16	+1.95%	23.7	207.25B
GILD	Gilead Sciences Inc	$150.56	+0.30%	—	187.10B
VRTX	Vertex Pharmaceuticals Inc	$510.72	+0.47%	29.7	130.64B
REGN	Regeneron Pharmaceuticals	$798.17	+1.70%	18.6	80.58B
ALNY	Alnylam Pharmaceuticals Inc	$244.32	+1.99%	40.0	32.33B

SRRK News

Scholar Rock's Isembyld Approval Fuels Launch Test, Shares Slip

Sep 14

Quick Stats

Market Cap5.97B

P/E Ratio—

EPS$-3.30

Volume—

SectorBiotechnology